Sarcopenia and inflammation are independent predictors of survival in male patients newly diagnosed with small cell lung cancer.
about
F-BOX proteins in cancer cachexia and muscle wasting: Emerging regulators and therapeutic opportunities.Validation of the Chinese version of functional assessment of anorexia-cachexia therapy (FAACT) scale for measuring quality of life in cancer patients with cachexia.The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature.Low Lean Mass With and Without Obesity, and Mortality: Results From the 1999-2004 National Health and Nutrition Examination Survey.Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: Results From the C SCANS Study.A comparison of pectoralis versus lumbar skeletal muscle indices for defining sarcopenia in diffuse large B-cell lymphoma - two are better than one.Evaluation of a prognostic scoring system based on the systemic inflammatory and nutritional status of patients with locally advanced non-small-cell lung cancer treated with chemoradiotherapy.An analysis of the types of recently published research in the field of cachexia.Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy.Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study.Evaluation of sarcopenia in small-cell lung cancer patients by routine chest CT.Prognostic Significance of Sarcopenia in Patients with Esophagogastric Junction Cancer or Upper Gastric Cancer.Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines.Prognostic Significance of Sarcopenia With Inflammation in Patients With Head and Neck Cancer Who Underwent Definitive ChemoradiotherapyLow pre-treatment nutritional index is significantly related to poor outcomes in small cell lung cancer
P2860
Q38577674-779F50C5-CF3B-4081-A8AD-6EBBF3B72060Q38789158-8017E134-ECCE-4D4A-8F22-0FDCADF922ADQ38842194-97C62997-5FD8-4D1F-AA4E-BDA95F106E99Q38957850-A2E465BD-1A23-4EE1-8ED0-CD790187E47EQ40087436-78521FCA-8EB2-4A7A-B2DF-B145D8433AF5Q41470871-E70CF822-D164-44FD-98A7-C9104E229BB7Q47356300-00293633-737D-4839-8403-D7757ED3473BQ47568983-ACDF25F9-EBA0-4F4B-BF08-B836CADF597EQ47801764-54C158B2-7868-43EF-8B5F-79E6A47D1A66Q49227916-FF77EF71-E1F7-441B-AF9F-EC50AAA5C131Q50881582-AFECCCC6-5438-4A2D-B5E6-E9185B9E4A80Q52951224-554BB4D2-065E-403A-8DDE-65F4FDF06F8FQ55196969-1F786340-0295-4A32-8110-670449DB714AQ59127762-B984CEEB-A9BD-4238-9EB1-12D1F2779BFAQ59137542-3EDBDE4B-6B81-4841-94D4-080E674040B1
P2860
Sarcopenia and inflammation are independent predictors of survival in male patients newly diagnosed with small cell lung cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Sarcopenia and inflammation ar ...... d with small cell lung cancer.
@en
type
label
Sarcopenia and inflammation ar ...... d with small cell lung cancer.
@en
prefLabel
Sarcopenia and inflammation ar ...... d with small cell lung cancer.
@en
P2093
P2860
P1476
Sarcopenia and inflammation ar ...... d with small cell lung cancer.
@en
P2093
Gyeong-Won Lee
Haa-Na Song
Hee Jung Park
Jung-Hun Kang
Kyung Nyeo Jeon
Mi Jung Park
Moon Jin Kim
Myoung Hee Kang
Seok-Hyun Kim
P2860
P2888
P304
P356
10.1007/S00520-015-2997-X
P577
2015-11-07T00:00:00Z